Company intelligence / Profile preview

Prescient Surgical

Menlo Park, California, United Statesprescientsurgical.com ↗

Ownership: Private
Development stage: Commercial

Overview

The CleanCision system has demonstrated safety and effectiveness in reducing bacterial contamination at incision sites. Clinical studies supported FDA de novo clearance in December 2016, followed by a second-generation product receiving FDA 510(k) clearance for commercial use in December 2017. Early clinical data attracted adoption among surgeons focused on infection control.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Collaborations with leading clinical partners/surgeons for trials, including Baylor Scott & White Health's Department of Surgery

Beyond the preview

Go deeper on Prescient Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prescient Surgical.

Explore the full profile